1.
Cancer Treat Rev
; 36 Suppl 3: S46-55, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21129610
RESUMO
Capecitabine is an orally administered fluoropyrimidine carbamate which has been developed as a prodrug of 5-FU with the goal to improve its tolerability and intratumoral drug concentration. The review aims to provide an evidence-based update of clinical trials investigating the clinical efficacy, adverse-event profile, dosage and administration of this drug, alone or in combination with conventional chemotherapeutics and/or new target-oriented drugs, in the management of colorectal cancer patients.